Scientific Advisory Board
Dr. William C. Little
Dr. William C. Little is the McMichael Professor of Medicine and Chief of Cardiology at Wake Forest University Baptist Medical Center in North Carolina. He has more than 225 peer-reviewed publications and is a member of the American Society for Clinical Investigation, Association of American Physicians and the Association of University Cardiologists. He received the 2010 Laennec Master Clinician Award from the American Heart Association. He serves on the American Board of Internal Medicine’s (ABIM) sub-specialty board on Cardiovascular Diseases and is a recognized leader in research on cardiac function.
Dr. Brian Olshansky
Dr. Brian Olshansky is a tenured Professor of Medicine and board certified clinical cardiac electrophysiologist at the University of Iowa Hospitals in Iowa where he directed the Clinical Cardiac Electrophysiology and the Fellowship Training Program for six years. He has taught ethics to medical students, and has been listed as one in Best Doctors in America for many years. Dr. Olshansky has been recognized globally for his expertise in the evaluation and treatment of cardiac arrhythmias, the assessment of arrhythmia mechanisms, , and multi-center randomized clinical arrhythmia trials. He has specific expertise in issues regarding autonomic effects on the heart. He is or has been a member of ten editorial boards including the Journal of the American College of Cardiology and the Journal of Cardiovascular Electrophysiology. He has lectured internationally and has been a visiting professor at institutions throughout the world. He is presently the Principal Investigator and originator of a multicenter clinical ICD trial (INTRINSIC RV) and is involved with recent data analyses regarding substudies of the AFFIRM and SCD-HeFT trials.
Dr. Milton Packer
Dr. Milton Packer is a Professor and a Gayle and Paul Stoffel Distinguished Chair in Cardiology and a Professor and the Chair of the Department of Clinical Sciences at the University of Texas Southwestern Medical School in Dallas, Texas. He is a founding member and prior president of the Heart Failure Society of America. Dr. Packer has served regularly as a consultant for the Food and Drug Administration as well as a member, principal investigator and/or the chairman of many landmark international multi-center trials. He is on the editorial board of a long list of prestigious journals. Dr. Packer is the recipient of numerous awards including the Lewis Katz Sr. Investigator Award.
Dr. Hani N. Sabbah
Dr. Hani N. Sabbah is a tenured Professor of Medicine at Wayne State University in Detroit and the Director of Cardiovascular Research at the Henry Ford Health System in Detroit. He is also an adjunct Professor of Medicine at the University of Maryland in Baltimore and Visiting Professor of Medicine at Columbia University in New York. Dr. Sabbah is internationally recognized for his basic and translational research in heart failure. He has extensive experience working with large animal models of heart failure focused on delineating mechanisms of myocardial disease and recovery and pre-clinical testing of new drugs and devices for the treatment of this disease syndrome. Dr. Sabbah also serves as Co-Editor-in-Chief of the journal "Heart Failure Reviews".
Dr. Peter J. Schwartz
Dr. Peter J. Schwartz, Chairman of Cardiology at the University of Pavia, is a world leader in the field of the autonomic nervous system and sudden cardiac death. In 1969 he demonstrated the cardio-cardiac sympathetic reflex and later the arrhythmogenic role of left cardiac sympathetic nerves, provided the experimental and clinical evidence that patients with reduced vagal reflexes are at higher risk for sudden death and that experimental vagal stimulation can prevent ventricular fibrillation, the background for vagal stimulation in man. Professor Schwartz served on the steering committees of international trials on sudden death, is on the editorial board of leading cardiovascular journals, and is the recipient of major awards including the "Paul Dudley White International Lecture" (AHA 1994); the “Michel Mirowski Award” (2001); the “NASPE Distinguished Scientist Award 2001”; and the Outstanding Achievement Award of ESC (2007). He is the only European investigator continuously funded by the N.I.H. for more than 30 years (1974-2012) and was the principal investigator of the European clinical study of BioControl’s CardioFit™ system for congestive heart failure.
Dr. Karl Swedberg
Dr. Karl Swedberg, Professor of Medicine, Head of the Department of Emergency and Cardiovascular Medicine at the Sahlgrenska Academy at University of Gothenburg, and senior physician in the Department of Medicine at Sahlgrenska University Hospital/Östra in Göteborg, Sweden was the first to report on the survival benefits of both ACE-inhibitors and beta-blockers in chronic heart failure. He has been a leading investigator or steering committee member in many international heart failure trials. He is the recipient of the Kaufman Award of Heart Failure Research 2004 from The Cleveland Clinic, Cleveland, USA. He also received the Gold medal from the European Society of Cardiology in 2007. Dr. Swedberg served as the Editor-in-Chief of the European Journal of Heart Failure, a leading Journal in this field between 2005 and 2009.
|
